Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022
Glucose Health, Inc. (OTC: GLUC) Quarterly Report – Q3 Fiscal 2022
BENTONVILLE, AR , Oct. 24, 2022 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022, posted today at OTCMarkets.com.
環球通訊社阿肯色州本頓維爾，2022年10月24日電葡萄糖健康公司(場外交易代碼：GLUC)(以下簡稱“公司”)今天在OTCMarkets.com上發佈了其2022財年第三季度報告中截至2022年9月30日的部分財務信息。
- Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase.
- Q3 2022 Gross Profit of $153,789 vs. $62,032 for Q3 2021 = a 148% increase.
- Q3 2022 Net Income of $8,091 vs. Q3 2021 Net Loss of $133,160.
- 2022年第三季度收入為340,681美元，而2021年第三季度為234,930美元=增長45%。
- 2022年第三季度毛利潤為153,789美元，而2021年第三季度為62,032美元=增長148%。
- Q3 2022 淨收入8,091美元與2021年第三季度淨虧損133,160美元。
The Company additionally advises shareholders and interested investors that a progress report regarding its planned up-listing to the NASDAQ Capital Market® stock exchange is expected to be issued by press release, the week of October 31, 2022.
公司還通知股東和感興趣的投資者，有關其計劃在納斯達克資本市場®證券交易所上市的進展報告預計將於2022年10月31日當週發佈新聞稿。
About Glucose Health, Inc. (OTC: GLUC)
關於葡萄糖健康公司(場外交易：GLUC)
By specializing in producing healthy and delicious beverages nutritionally appropriate1 for the nation's 100+ million2 pre and Type-2 diabetics, and additionally, with its planned launch of a new healthy and delicious soluble fiber infused "ready-to-drink" beverage, formulated to meet the nutritional needs of the 95% of Americans who are considered fiber deficient3, Glucose Health, Inc. is uniquely positioned among all micro-cap beverage companies in America. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.
通過專業生產健康美味的營養適宜的飲料1 為這個國家的1億多人2此外，該公司還計劃推出一種新的健康美味的可溶性纖維注入即飲飲料，其配方是為了滿足95%被認為是纖維缺乏的美國人的營養需求3，葡萄糖健康公司在美國所有微型飲料公司中具有獨特的地位。葡萄糖健康公司是一家上市公司，股票代碼為OTC：GLUC。
For more GLUC news visit:
Like us on Facebook at:
有關更多GLUC新聞，請訪問： 在Facebook上點讚我們：
1 For citations visit
2 National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services
3Closing America's Fiber Intake Gap.
1 如需引用，請訪問2 《2020年國家糖尿病統計評論》衞生和公眾服務部疾病控制和預防中心
3縮小美國的纖維攝入量差距.
Contact:
Murray Fleming
Glucose Health, Inc.
info@glucosehealthinc.com
(479) 802-3827
聯繫方式：
默裏·弗萊明
葡萄糖健康公司
郵箱：INFO@GIGROSEHANTHINC.com(479) 802-3827
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.
本新聞稿包含符合修訂的1933年證券法第27A節的前瞻性陳述，雖然葡萄糖健康公司不受1934年證券交易法的約束，但包含符合1934年修訂的證券交易法第21E節的前瞻性陳述。不描述歷史事實的陳述構成前瞻性陳述，可能經常但不總是通過使用“預期”、“預期”、“打算”、“估計”、“計劃”、“可能”、“相信”、“尋求”、“可能”、“將”、“應該”、“可能”或此類術語的否定或其他類似表述來識別。由於公司業務中固有的風險和不確定性，實際結果可能與本新聞稿中陳述的結果大不相同。告誡讀者不要過度依賴這些前瞻性陳述，這些陳述僅在本文發表之日起發表。所有前瞻性陳述都受本警示聲明的限制，公司沒有義務修改或更新本新聞稿，以反映此後發生的事件或情況。
譯文內容由第三人軟體翻譯。